CAS Medical Systems has been cleared by the FDA to market its FORE-SIGHT ELITE Absolute Tissue Oximeter, a next-generation device used to provide transitional adolescent and adult patients who weigh at least 40 kilograms with absolute cerebral oxygenation levels. The company plans to release the device during the fourth quarter of this year.
CAS Medical's next-gen tissue oximeter gains 510(k) clearance
SmartBrief Job Listings for Health Care
Attest Health Care Advisors
|Biotechnology/Pharmaceutical Patent Attorney||
Coats and Bennett PLLC
|Sr. Regulatory Specialist, Biotech Center of Expertise||
BASF, The Chemical Co.
|San Diego, CA|
Meridian Health Plan